Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Tuesday 9 June at 4:30pm because of system upgrades. We expect to open them again on Wednesday 10 June at 8am the latest.

To main content To sitemap To news Check availability details

Determining Biomarkers of Efficacy in DC Reprogramming Therapy

Reference number
Coordinator Asgard Therapeutics AB
Funding from Vinnova SEK 0
Project duration April 2024 - April 2024
Status Completed
Venture MSCA Employment
Call Attract, integrate and retain international excellence by 2024

Last updated 29 April 2024

Reference number 2024-00579